Cryo-Cell International Inc. · Healthcare · Healthcare
As of 2026-06-26, Cryo-Cell International Inc. (CCEL) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.8%, relative volume 3.61×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
36 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
CCEL is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $336K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $336K |
| VXFVanguard Extended Market ETF | 0.00% | $117K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CCEL Jan avg: -3.06% median: -3.99% win: 25% σ: 6.04% n: 4 2022-04-13 → 2026-05-29 | CCEL Feb avg: -0.45% median: 0.61% win: 50% σ: 3.50% n: 4 2022-04-13 → 2026-05-29 | CCEL Mar avg: 1.89% median: -7.48% win: 50% σ: 30.04% n: 4 2022-04-13 → 2026-05-29 | CCEL Apr avg: 16.46% median: -3.66% win: 40% σ: 51.85% n: 5 2022-04-13 → 2026-05-29 | CCEL May avg: -5.90% median: -2.08% win: 0% σ: 9.24% n: 5 2022-04-13 → 2026-05-29 | CCEL Jun avg: 3.89% median: -1.19% win: 50% σ: 14.77% n: 4 2022-04-13 → 2026-05-29 (current) | CCEL Jul avg: -4.56% median: -4.20% win: 0% σ: 3.45% n: 4 2022-04-13 → 2026-05-29 | CCEL Aug avg: 3.51% median: 2.15% win: 50% σ: 18.03% n: 4 2022-04-13 → 2026-05-29 | CCEL Sep avg: -7.01% median: -6.77% win: 25% σ: 9.31% n: 4 2022-04-13 → 2026-05-29 | CCEL Oct avg: -1.49% median: -1.50% win: 25% σ: 13.69% n: 4 2022-04-13 → 2026-05-29 | CCEL Nov avg: 0.74% median: -1.38% win: 50% σ: 12.98% n: 4 2022-04-13 → 2026-05-29 | CCEL Dec avg: -7.57% median: -8.87% win: 25% σ: 12.23% n: 4 2022-04-13 → 2026-05-29 |